Michael Keng
University of Miami Health System
ORCID: 0000-0002-7679-6514Also affiliated with University of Virginia
Medicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia”.
2 citations
Rachel J. Cook, Shira Dinner, Michael Keng, Kebede H. Begna, Nathalie Javidi‐Sharifi +9 more
3 citations
Sarah Holte, Yuzheng Zhang, Immaculate Mbarusha, Dennis Mubiru, Bernadette Pedun +6 more